Back to Companies
Vir Biotechnology, Inc.
VIRNasdaqCIK: 0001706431
Vir Biotechnology, Inc. (VIR) shows 44 recent insider filings from 14 insiders, with all of them on the sell side. With $0 in purchases and $14.9M in sales, the recent tape is heavily weighted toward selling (net sales of $14.9M). SVF Endurance (Cayman) Ltd (10% Owner) is the most active by dollar volume, and the single largest transaction was $4.5M by De Backer Marianne. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$23.3M
Purchases
$0
Sales
$14.9M
Unique Insiders
14
Recent Insider Trades
44 loaded
| Jun 10 | VIR Vir Biotechnology, Inc. | Coughlin Timothy | Director | Grant | $272.3K |
| Jun 10 | VIR Vir Biotechnology, Inc. | Coughlin Timothy | Director | Other | $0 |
| Jun 2 | VIR Vir Biotechnology, Inc. | Napolitano Janet | Director | Sell | $30.2K |
| Jun 2 | VIR Vir Biotechnology, Inc. | Sabatini Brent | SVP, Chief Accounting Officer | Sell | $3.6K |
| May 28 | VIR Vir Biotechnology, Inc. | Napolitano Janet | Director | Grant | $145.6K |
| May 28 | VIR Vir Biotechnology, Inc. | Sigal Charles Elliott | Director | Grant | $145.6K |
| May 28 | VIR Vir Biotechnology, Inc. | MORE ROBERT J | Director | Grant | $145.6K |
| May 28 | VIR Vir Biotechnology, Inc. | Farid Ramy | Director | Grant | $145.6K |
| May 28 | VIR Vir Biotechnology, Inc. | Hatfield Jeffrey S. | Director | Grant | $145.6K |
| May 28 | VIR Vir Biotechnology, Inc. | BISCHOFBERGER NORBERT W | Director | Grant | $145.6K |
| May 4 | VIR Vir Biotechnology, Inc. | SATO VICKI L | Director | Sell | $221.0K |
| Apr 30 | VIR Vir Biotechnology, Inc. | De Backer Marianne | President and CEO, Director | Other | $0 |
| Apr 7 | VIR Vir Biotechnology, Inc. | De Backer Marianne | President and CEO, Director | Sell | $664.4K |
| Apr 2 | VIR Vir Biotechnology, Inc. | SATO VICKI L | Director | Sell | $199.6K |
| Mar 24 | VIR Vir Biotechnology, Inc. | Sabatini Brent | SVP, Chief Accounting Officer | Sell | $70.3K |
| Mar 23 | VIR Vir Biotechnology, Inc. | O'Byrne Jason | EVP & Chief Financial Officer | Other | $0 |
| Mar 3 | VIR Vir Biotechnology, Inc. | SATO VICKI L | Director | Sell | $209.2K |
| Feb 26 | VIR Vir Biotechnology, Inc. | SATO VICKI L | Director | Sell | $413.4K |
| Feb 26 | VIR Vir Biotechnology, Inc. | Eisner Mark | EVP and Chief Medical Officer | Sell | $34.0K |
| Feb 26 | VIR Vir Biotechnology, Inc. | O'Byrne Jason | EVP & Chief Financial Officer | Sell | $15.6K |
| Feb 26 | VIR Vir Biotechnology, Inc. | Sabatini Brent | SVP, Chief Accounting Officer | Sell | $13.6K |
| Feb 24 | VIR Vir Biotechnology, Inc. | Eisner Mark | EVP and Chief Medical Officer | Sell | $15.6K |
| Feb 24 | VIR Vir Biotechnology, Inc. | O'Byrne Jason | EVP & Chief Financial Officer | Sell | $15.6K |
| Feb 24 | VIR Vir Biotechnology, Inc. | Sabatini Brent | SVP, Chief Accounting Officer | Sell | $13.6K |
| Feb 24 | VIR Vir Biotechnology, Inc. | de Verneuil Vanina | EVP, General Counsel, Corp Sec | Sell | $33.1K |
| Feb 24 | VIR Vir Biotechnology, Inc. | De Backer Marianne | Chief Executive Officer, Director | Sell | $141.9K |
| Feb 18 | VIR Vir Biotechnology, Inc. | Sabatini Brent | SVP, Chief Accounting Officer | Sell | $11.9K |
| Feb 3 | VIR Vir Biotechnology, Inc. | SATO VICKI L | Director | Sell | $169.7K |
| Jan 5 | VIR Vir Biotechnology, Inc. | SATO VICKI L | Director | Sell | $130.4K |
| Dec 2 | VIR Vir Biotechnology, Inc. | SATO VICKI L | Director | Sell | $132.1K |
| Nov 18 | VIR Vir Biotechnology, Inc. | O'Byrne Jason | EVP & Chief Financial Officer | Sell | $37.8K |
| Nov 7 | VIR Vir Biotechnology, Inc. | de Verneuil Vanina | EVP, General Counsel, Corp Sec | Sell | $12.3K |
| Nov 4 | VIR Vir Biotechnology, Inc. | de Verneuil Vanina | EVP and General Counsel | Sell | $8.0K |
| Nov 4 | VIR Vir Biotechnology, Inc. | SATO VICKI L | Director | Sell | $124.0K |
| Oct 24 | VIR Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | $1.8M |
| Oct 22 | VIR Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | $2.1M |
| Oct 17 | VIR Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | $179.6K |
| Oct 14 | VIR Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | $1.5M |
| Oct 9 | VIR Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | $3.2M |
| Oct 7 | VIR Vir Biotechnology, Inc. | SVF Endurance (Cayman) Ltd | 10% Owner | Sell | $2.9M |
| Oct 2 | VIR Vir Biotechnology, Inc. | SATO VICKI L | Director | Sell | $128.4K |
| Sep 3 | VIR Vir Biotechnology, Inc. | SATO VICKI L | Director | Sell | $109.8K |
| Aug 4 | VIR Vir Biotechnology, Inc. | SATO VICKI L | Director | Sell | $109.7K |
| Jul 17 | VIR Vir Biotechnology, Inc. | Eisner Mark | EVP and Chief Medical Officer | Sell | $56.8K |
44 filings